Home About Us Services Markets Online Trading Back Office Contact Us Download Mutual Fund
Cipla Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
 BSE Code
 500087
ISIN Demat
INE059A01026
Book Value
411.5600262
Mar.Cap(Rs.Cr)
122,555.05
P/E
23.58
Face Value
2
Go
Your are on :   Markets   |  Company Profile   |  Board Of Directors
Chairman (Non-Executive)Y K Hamied
Non Executive DirectorAdil Zainulbhai
Managing Director & Global CEOUmang Vohra
Company Sec. & Compli. OfficerRajendra Chopra
Independent DirectorRobert A Stewart
P R Ramesh
Mandar Purushottam Vaidya
Non Executive DirectorAbhijit A Joshi
Kamil Hamied
Independent DirectorSharmila Paranjpe
Maya Hari
Dr Balram Bhargava
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores 2.0 Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in
Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR|  Saa₹thi  |  View Client Collateral Details  |  
Vernacular Languages  |  Online Freezing/Blocking Account  |  Advisory for Investor
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)